Nolan Townsend

Nolan Townsend serves as the Chief Executive Officer of LEXEO Therapeutics since January 2020 and is actively involved as a Board Member for both the Biotechnology Innovation Organization and Arbor Biotechnologies as of October 2023. Additionally, Nolan holds the position of Chairman of The Board of Directors for Life Science Cares New York from 2022 to 2024. Prior experience includes various leadership roles at Pfizer from 2003 to 2020, where Nolan advanced from Analyst in Corporate Finance to President of North America for Pfizer Rare Disease. Nolan’s career also features an Associate role in Healthcare Investment Banking at Lehman Brothers from 2006 to 2008. Educational qualifications include an MBA from Harvard Business School and a BA in Economics from the University of Pennsylvania.